The advent of combination antiretroviral therapy (cART) in 1996, led to a decreased incidence of several cancers, in particular AIDS-defining malignancies (ADMs, i.e. Kaposi sarcoma-KS, Non-Hodgkin lymphoma-NHL and Invasive Cervical Cancer-ICC), and among non-AIDS defining malignancies (NADMs) of virus-related e.g. Hodgkin’s lymphoma (HL) or anal cancer. In our study, we quantified the incidence of cancer in a Large Italian cohort of ART-naïve persons with HIV or AIDS (PWHAs) HIV-diagnosed in the last 20 years (ICONA cohort).
Still high risk of virus-related cancer despite 20 years of Cart in ICONA cohort.
G. Nunnari;G. F. Pellicanò.
2018-01-01
Abstract
The advent of combination antiretroviral therapy (cART) in 1996, led to a decreased incidence of several cancers, in particular AIDS-defining malignancies (ADMs, i.e. Kaposi sarcoma-KS, Non-Hodgkin lymphoma-NHL and Invasive Cervical Cancer-ICC), and among non-AIDS defining malignancies (NADMs) of virus-related e.g. Hodgkin’s lymphoma (HL) or anal cancer. In our study, we quantified the incidence of cancer in a Large Italian cohort of ART-naïve persons with HIV or AIDS (PWHAs) HIV-diagnosed in the last 20 years (ICONA cohort).File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
